About Us
«Prueba Para la Vida, Preventive oncology International Mexico A.C.», was inaugurated on 16 October 2002 with the purpose of developing an effective, acceptable and economic protocol to detect cancerous and precancerous cervical lesions.
«Prueba Para la Vida, Preventive oncology International Mexico A.C.» features the most advanced technology to carry out the detection of 13 types of human papillomavirus (HPV), medium and high risk (16,18, 31, 33, 35, 39, 45 , 51, 52, 56, 58, 59 and 68). These types are those that cause cervical cancer. This test is performed by Hybrid Capture 2 (DIGENE) and detects the presence of DNA of high-risk HPV in samples of cervix and vagina. Sensitivity 96-98% by direct shot. The results are given in 5 business days. Women who test positive, they conducted further studies rule out cancerous lesions of the cervix.
Rotary International funded the program began, and requested the collaboration of recognized to direct and supervise the program researchers. Doctors Jerome Belinson Cleveland Clinic Foundation, Dr. Robert Pretorius Kaiser Permanente and Dr. Francisco Garcia University of Arizona, established a medical protocol for screening the first 10,000 women.
In May 2010, the organization has diversified its services by installing an analytical laboratory to provide assistance CLINICOS clinical analysis service to the community, with the purpose of generating financial resources and achieve self-sustainability.
«Prueba Para la Vida» ha realizado más de 25 mil pruebas para detección de VPH desde el año 2002